George Dalekos

Greece

Research Interests

Explore related searches

Professors in Immunology

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (27)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (13)

George Simos

Professor

University of Thessaly

GREECE

View details

Theoharis C. Theoharides

Tufts University School of Medicine

UNITED STATES

View details

Matthaios Speletas

University of Thessaly

GREECE

View details

Alessio Gerussi

Lecturer

University of Milano-Bicocca

ITALY

View details

Giorgina Mieli-Vergani

Emeritus Professor of Paediatric Hepatology

King’s College London

UNITED KINGDOM

View details

Ricardo Gomez Huelgas

Titular Professor

University of Malaga

SPAIN

View details

Dina Tiniakos

Newcastle University

UNITED KINGDOM

View details

Deutsch Maria Melanie

Associate Professor

GREECE

View details

Christos Triantos

University Hospital of Patras

GREECE

View details

Dimitrios Christodoulou

University Hospital of Ioannina

GREECE

View details

John Vierling

Professor of Medicine and Surgery (tenured); Chief of Hepatology

Baylor College of Medicine

UNITED STATES

View details

NIKOLAOS PAPADOPOULOS

Head

GREECE

View details

Maria Papp

HUNGARY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

George Dalekos

Research Interests

Explore related searches

Contact this professor

Articles (27)

Cell-specific epigenome-wide DNA methylation in peripheral CD4(+) lymphocytes from patients with primary biliary cholangitis

Reply to: “The role of liver biopsy in diagnosing patients with autoimmune hepatitis – it can be acceptable to skip!”

IgG Baseline Serum Levels and Prognosis of Primary Biliary Cholangitis

Management of asymptomatic patients with abnormal liver function tests

Intermediate care units in internal medicine – From concept to consolidation

Increased IgG Levels at Diagnosis Are Associated With Worse Prognosis of Patients With Primary Biliary Cholangitis

TLR4 and TNF-α single nucleotide polymorphisms in patients with brucellosis: Association with infection complications

PNPLA3 I148 M genetic variant in autoimmune hepatitis characterises advanced disease at diagnosis and reduced survival free of cirrhotic events and liver-related mortality

Long‐term outcome of hepatitis delta in different regions world‐wide: Results of the Hepatitis Delta International Network

Internal medicine in the 21st century: Back to the future

Unmet needs in autoimmune hepatitis: Results of the prospective multicentre European Reference Network Registry (R‐LIVER)

Artificial intelligence supported ultrasonography: Can it be the solution for early and accurate diagnosis of steatotic liver disease?

Osteonecrosis risk after steroids-related treatment of COVID-19 is not negligible: A cross sectional study

Second- and third-line treatment agents in autoimmune hepatitis (AIH): Where do we stand?

New horizons in the diagnosis and management of patients with MASLD

The Effect of Biologic Agents on Steatotic Liver Disease in Patients with Inflammatory Bowel Disease: A Prospective, Open-Label Comparative Trial

<scp>HERACLIS‐HDV</scp> cohort for the factors of underdiagnosis and prevalence of hepatitis D virus infection in <scp>HBsAg</scp>‐positive patients

Systematic review of response criteria and endpoints in autoimmune hepatitis by the International Autoimmune Hepatitis Group

Hepcidin as a Sensitive and Treatment-Responsive Acute-Phase Marker in Patients with Bacteremia: A Pilot Study

Long-term results of mycophenolate mofetil vs. azathioprine use in individuals with autoimmune hepatitis

Altered DNA methylation pattern characterizes the peripheral immune cells of patients with autoimmune hepatitis

Calprotectin and Imbalances between Acute-Phase Mediators Are Associated with Critical Illness in COVID-19

SARS‐CoV‐2 Infections Among Patients With Liver Disease and Liver Transplantation Who Received COVID‐19 Vaccination

Autoimmune hepatitis in patients aged 70 years or older: Disease characteristics, treatment response and outcome

Predictive performance of newer Asian hepatocellular carcinoma risk scores in treated Caucasians with chronic hepatitis B

An Immunocompetent HIV-Negative Elderly Patient with Low-Grade Fever, Generalized Lymphadenopathy, Splenomegaly, and Acute Phase Response: Do Not Forget Castleman Disease

Update of the simplified criteria for autoimmune hepatitis: Evaluation of the methodology for immunoserological testing

Collaborators (13)

George Simos

Theoharis C. Theoharides

Matthaios Speletas

Alessio Gerussi

Giorgina Mieli-Vergani

Ricardo Gomez Huelgas

Dina Tiniakos

Deutsch Maria Melanie

Christos Triantos

Dimitrios Christodoulou

John Vierling

NIKOLAOS PAPADOPOULOS

Maria Papp

Make your next move.